ADVISORY PANEL VOTED 6-1 TO RECOMMEND THAT US FDA DECLINE TO APPROVE DUROLANE INJECTION

Share this story with your network

WASHINGTON, Aug 19 (Reuters) – A U.S. Food and Drug Administration advisory panel on Wednesday:

REJECTED DUROLANE KNEE PAIN INJECTION FROM Q-MED AND SMITH & NEPHEW

VOTED 6-1 TO RECOMMEND THAT US FDA DECLINE TO APPROVE DUROLANE INJECTION (Company news desk in Washington; +1 202 898 8400, washington.newsroom@reuters.com)

COPYRIGHT

Leave a Comment

Your email address will not be published. Required fields are marked *

*